Hologic, Inc. (HOLX) Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 9.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,535,196 shares of the medical equipment provider’s stock after selling 163,585 shares during the period. Hologic comprises 1.3% of Segall Bryant & Hamill LLC’s portfolio, making the stock its 12th biggest position. Segall Bryant & Hamill LLC owned 0.56% of Hologic worth $56,326,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HOLX. Hall Laurie J Trustee increased its holdings in shares of Hologic by 10.2% in the 2nd quarter. Hall Laurie J Trustee now owns 2,425 shares of the medical equipment provider’s stock valued at $110,000 after acquiring an additional 225 shares during the period. Commonwealth Bank of Australia increased its holdings in shares of Hologic by 31.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 2,533 shares of the medical equipment provider’s stock valued at $114,000 after acquiring an additional 600 shares during the period. Grove Bank & Trust increased its holdings in shares of Hologic by 115.8% in the 3rd quarter. Grove Bank & Trust now owns 2,860 shares of the medical equipment provider’s stock valued at $105,000 after acquiring an additional 1,535 shares during the period. National Asset Management Inc. purchased a new position in shares of Hologic in the 2nd quarter valued at $203,000. Finally, Cambridge Investment Research Advisors Inc. purchased a new position in shares of Hologic in the 2nd quarter valued at $213,000. 98.09% of the stock is owned by institutional investors and hedge funds.

In related news, Director Lawrence M. Levy sold 7,138 shares of the business’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $37.38, for a total transaction of $266,818.44. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Lawrence M. Levy sold 9,596 shares of the business’s stock in a transaction on Tuesday, October 10th. The stock was sold at an average price of $36.81, for a total value of $353,228.76. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,833 shares of company stock worth $1,107,270. 0.79% of the stock is owned by company insiders.

Hologic, Inc. (NASDAQ HOLX) opened at $41.44 on Thursday. Hologic, Inc. has a one year low of $35.76 and a one year high of $46.80. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.61 and a current ratio of 0.79. The firm has a market capitalization of $11,548.39, a price-to-earnings ratio of 20.74, a P/E/G ratio of 2.03 and a beta of 0.95.

Hologic (NASDAQ:HOLX) last announced its earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.01. Hologic had a return on equity of 21.69% and a net margin of 24.70%. The firm had revenue of $802.90 million for the quarter, compared to the consensus estimate of $792.54 million. During the same period in the previous year, the business earned $0.52 EPS. The firm’s revenue for the quarter was up 10.5% on a year-over-year basis. analysts predict that Hologic, Inc. will post 2.12 earnings per share for the current year.

A number of research analysts have recently issued reports on HOLX shares. Needham & Company LLC reiterated a “buy” rating and issued a $50.00 price target on shares of Hologic in a report on Monday, October 2nd. Piper Jaffray Companies reiterated a “buy” rating and issued a $48.00 price target on shares of Hologic in a report on Thursday, November 9th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $45.00 price target (down from $50.00) on shares of Hologic in a report on Wednesday, August 9th. Barclays reiterated an “equal weight” rating and issued a $51.00 price target (down from $53.00) on shares of Hologic in a report on Wednesday, August 9th. Finally, Jefferies Group reiterated a “buy” rating and issued a $44.00 price target (down from $49.00) on shares of Hologic in a report on Tuesday, October 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $47.38.

WARNING: “Hologic, Inc. (HOLX) Shares Sold by Segall Bryant & Hamill LLC” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3078970/hologic-inc-holx-shares-sold-by-segall-bryant-hamill-llc.html.

Hologic Company Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.